English  |  正體中文  |  简体中文  |  2832440  
???header.visitor??? :  33796550    ???header.onlineuser??? :  1214
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hsiao l t"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 18  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-06-10T06:11:12Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; ZHONG-ZHE LIN; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2022-01-12T07:07:28Z Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma Hsiao L.-T.; Tien H.-F.; Kuo C.-Y.; Wu J.-H.; HSIN-AN HOU; Wang M.-C.; Liu C.-Y.; Chen P.-M.; Chiou T.-J.
臺大學術典藏 2021-09-01T01:54:16Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; ANN-LII CHENG
臺大學術典藏 2021-08-11T03:46:49Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; ZHONG-ZHE LIN; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:46Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2021-02-05T06:29:19Z Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes Wen-Chien Chou;Yeh S.-P.;Hsiao L.-T.;Lin S.-F.;Chen Y.-C.;Chen T.-Y.;Laille E.;Galettis A.;Dong Q.;Songer S.;Beach C.L.; WEN-CHIEN CHOU; Yeh S.-P.; Hsiao L.-T.; Lin S.-F.; Chen Y.-C.; Chen T.-Y.; Laille E.; Galettis A.; Dong Q.; Songer S.; Beach C.L.
臺大學術典藏 2021-02-03T03:28:39Z Human cytokine genetic variants associated with HBsAg reverse seroconversion in rituximab-treated non-hodgkin lymphoma patients Hsiao L.-T.; Wang H.-Y.; Yang C.-F.; Chiou T.-J.; Gau J.-P.; Yu Y.-B.; Liu H.-L.; WEN-CHUN CHANG; Chen P.-M.; Tzeng C.-H.; Chan Y.-J.; Yang M.-H.; Liu J.-H.; Huang Y.-H.
臺大學術典藏 2021-01-06T03:58:43Z Haematopoietic stem cell transplantation in Taiwan: Past, present, and future Chen P.M.; Hsiao L.T.; JIH-LUH TANG; Yen C.C.; Liu J.H.; Chiou T.J.; Tzeng C.H.; Lin K.H.
臺大學術典藏 2020-04-28T07:25:28Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Chih-Hung Hsu;Yang T.-S.;Hsu C.;Toh H.C.;Epstein R.J.;Hsiao L.-T.;Chen P.-J.;Lin Z.-Z.;Chao T.-Y.;Cheng A.-L.; CHIH-HUNG HSU; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:51:20Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.;Yang T.-S.;Chiun Hsu;Toh H.C.;Epstein R.J.;Hsiao L.-T.;Chen P.-J.;Lin Z.-Z.;Chao T.-Y.;Cheng A.-L.; Hsu C.-H.; Yang T.-S.; Chiun Hsu; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.

Showing items 1-10 of 18  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page